Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03568708 · ClinicalTrials.gov registry record · Phase 3
Primary Ovarian Insufficiency: Phenotype and Optimal Treatment
A Phase 3 study of Primary Ovarian Insufficiency, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 3
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT03568708 is a Phase 3 study of Primary Ovarian Insufficiency that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 19 participants, below the 179-participant average among 3 other Primary Ovarian Insufficiency trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03568708, a Phase 3 study of Primary Ovarian Insufficiency, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study will observe the progression of newly diagnosed POI patients physical and psychology outcomes after initiating standard of care HRT treatment in comparison to healthy female control participants' physical and psychology health over 24 months.
Conditions Studied
Interventions
- DRUG Transdermal Estrogen
Study Locations (1)
Ohio
- Cincinnati Children's Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2023-01-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03568708
The ClinicalTrials.gov registry entry for NCT03568708 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 3 other Primary Ovarian Insufficiency trials with a reported enrollment target (89% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Ovarian Insufficiency appearing as the primary indexed condition, and to 1 intervention - of which Transdermal Estrogen is the first listed.
NCT03568708 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03568708 about?
NCT03568708 is a clinical study titled "Primary Ovarian Insufficiency: Phenotype and Optimal Treatment". This pilot study will observe the progression of newly diagnosed POI patients physical and psychology outcomes after initiating standard of care HRT treatment in comparison to healthy female control participants' physical and psychology health over 24 months.
What is the current status of trial NCT03568708?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 19 participants. The study started on 2018-11-01. Estimated completion is 2023-01-05.
What conditions does trial NCT03568708 study?
This clinical trial studies the following conditions: Primary Ovarian Insufficiency.
What interventions are being tested in trial NCT03568708?
The interventions under investigation include: Transdermal Estrogen (DRUG).
Who is sponsoring clinical trial NCT03568708?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03568708 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Ovarian Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.
RECRUITING
-
Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)
RECRUITING
-
Rejuvenation of Premature Ovarian Failure With Stem Cells
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.